Cargando…
The β-adrenergic receptor blocker and anti-inflammatory drug propranolol mitigates brain cytokine expression in a long-term model of Gulf War Illness
AIMS: Growing evidence suggests that Gulf War Illness (GWI) is the result of underlying neuroimmune dysfunction. For example, previously we found that several GWI-relevant organophosphate acetylcholinesterase inhibitors produce heightened neuroinflammatory responses following subchronic exposure to...
Autores principales: | Michalovicz, Lindsay T., Kelly, Kimberly A., Miller, Diane B., Sullivan, Kimberly, O’Callaghan, James P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047058/ https://www.ncbi.nlm.nih.gov/pubmed/34563566 http://dx.doi.org/10.1016/j.lfs.2021.119962 |
Ejemplares similares
-
Supporting a Neuroimmune Basis of Gulf War Illness
por: O'Callaghan, James P., et al.
Publicado: (2016) -
Advancing the Role of Neuroimmunity and Genetic Susceptibility in Gulf War Illness
por: O'Callaghan, James P., et al.
Publicado: (2017) -
Oligodendrocyte involvement in Gulf War Illness
por: Belgrad, Jillian, et al.
Publicado: (2019) -
Acetylcholinesterase inhibitor exposures as an initiating factor in the development of Gulf War Illness, a chronic neuroimmune disorder in deployed veterans
por: Michalovicz, Lindsay T., et al.
Publicado: (2020) -
Corticosterone primes the neuroinflammatory response to Gulf War Illness‐relevant organophosphates independently of acetylcholinesterase inhibition
por: Locker, Alicia R., et al.
Publicado: (2017)